These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25351552

  • 1. In vitro cytotoxicity of 4'-OH-tamoxifen and estradiol in human endometrial adenocarcinoma cells HEC-1A and HEC-1B.
    Cuevas ME, Lindeman TE.
    Oncol Rep; 2015 Jan; 33(1):464-70. PubMed ID: 25351552
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y, Ballejo G, Murphy LC, Murphy LJ.
    Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100
    [Abstract] [Full Text] [Related]

  • 3. Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
    Treeck O, Wackwitz B, Haus U, Ortmann O.
    Gynecol Oncol; 2006 Aug 01; 102(2):292-9. PubMed ID: 16443261
    [Abstract] [Full Text] [Related]

  • 4. Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts.
    Gong Y, Murphy LC, Murphy LJ.
    J Steroid Biochem Mol Biol; 1994 Jul 01; 50(1-2):13-9. PubMed ID: 8049128
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R.
    Oncogene; 2004 Jun 17; 23(28):4945-58. PubMed ID: 15094777
    [Abstract] [Full Text] [Related]

  • 6. Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines.
    Vendrell JA, Bieche I, Desmetz C, Badia E, Tozlu S, Nguyen C, Nicolas JC, Lidereau R, Cohen PA.
    Endocr Relat Cancer; 2005 Mar 17; 12(1):75-92. PubMed ID: 15788640
    [Abstract] [Full Text] [Related]

  • 7. Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells.
    Lim YC, Li L, Desta Z, Zhao Q, Rae JM, Flockhart DA, Skaar TC.
    J Pharmacol Exp Ther; 2006 Aug 17; 318(2):503-12. PubMed ID: 16690721
    [Abstract] [Full Text] [Related]

  • 8. [Study on the modulation of estrogen receptor isoforms alpha in endometrial carcinoma cells using antisense oligodeoxyribonucleotides].
    Zhang Y, Liao QP, Yu L, Chen CL, Zhao J.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr 18; 37(2):155-8. PubMed ID: 15841144
    [Abstract] [Full Text] [Related]

  • 9. Tamoxifen modulates apoptotic pathways in primary endometrial cell cultures.
    Stackievicz R, Drucker L, Radnay J, Beyth Y, Yarkoni S, Cohen I.
    Clin Cancer Res; 2001 Feb 18; 7(2):415-20. PubMed ID: 11234898
    [Abstract] [Full Text] [Related]

  • 10. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
    Czeczuga-Semeniuk E, Wołczyński S, Dabrowska M, Dziecioł J, Anchim T.
    Folia Histochem Cytobiol; 2004 Feb 18; 42(4):221-7. PubMed ID: 15704648
    [Abstract] [Full Text] [Related]

  • 11. Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells.
    Acconcia F, Barnes CJ, Kumar R.
    Endocrinology; 2006 Mar 18; 147(3):1203-12. PubMed ID: 16339197
    [Abstract] [Full Text] [Related]

  • 12. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 18; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 13. Function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells.
    Zhang Y, Liao Q, Chen C, Yu L, Zhao J.
    Int J Gynecol Cancer; 2006 Mar 18; 16(4):1656-60. PubMed ID: 16884380
    [Abstract] [Full Text] [Related]

  • 14. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
    Zhou L, Cai B, Bao W, He YY, Chen XY, Yang YX, Liu XL, Wan XP.
    Int J Gynecol Cancer; 2011 Nov 18; 21(8):1357-65. PubMed ID: 21720253
    [Abstract] [Full Text] [Related]

  • 15. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H.
    Cancer Res; 1984 May 18; 44(5):2084-8. PubMed ID: 6713400
    [Abstract] [Full Text] [Related]

  • 16. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
    Catherino WH, Wolf DM, Jordan VC.
    Mol Endocrinol; 1995 Aug 18; 9(8):1053-63. PubMed ID: 7476979
    [Abstract] [Full Text] [Related]

  • 17. Tamoxifen exerts oestrogen-agonistic effects on proliferation and plasminogen activation, but not on gelatinase activity, glycogen metabolism and p53 protein expression, in cultures of oestrogen-responsive human endometrial adenocarcinoma cells.
    Hochner-Celnikier D, Greenfield C, Finci-Yeheskel Z, Milwidsky A, Gutman A, Goldman-Wohl D, Yagel S, Mayer M.
    Mol Hum Reprod; 1997 Dec 18; 3(12):1019-27. PubMed ID: 9464846
    [Abstract] [Full Text] [Related]

  • 18. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
    Kallio A, Zheng A, Dahllund J, Heiskanen KM, Härkönen P.
    Apoptosis; 2005 Dec 18; 10(6):1395-410. PubMed ID: 16215679
    [Abstract] [Full Text] [Related]

  • 19. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 Dec 18; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D, tamoxifen and beta-estradiol modulate breast cancer cell growth and interleukin-6 and metalloproteinase-2 production in three-dimensional co-cultures of tumor cell spheroids with endothelium.
    Paduch R, Kandefer-Szerszeń M.
    Cell Biol Toxicol; 2005 Dec 18; 21(5-6):247-56. PubMed ID: 16323060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.